how to buy bngo stock

Where can I buy shares of bngo?

May 21, 2021 · How to Buy BNGO Stock Pick a brokerage. Retail investors like yourself are buying stocks through the brokers. Brokers serve as licensed... Decide how many shares you want. After you open and fund your brokerage account you’re ready to buy the shares. The... Choose your order type. There are ...

Should you buy BioNano genomics (bngo) stock?

Oct 29, 2020 · How to buy shares in Bionano Genomics Compare share trading platforms. Use our comparison table to help you find a platform that fits you. Open your brokerage account. Complete an application with your details. Confirm your payment details. Fund your account. Research the stock. Find the stock by ...

Is bngo a good stock to buy for momentum investors?

Apr 08, 2022 · BioNano Genomics Inc. stock price down 4.42% on Friday(Updated on Apr 22, 2022) The BioNano Genomics Inc. stock price fell by -4.42% on the last day (Friday, 22nd Apr 2022) from $1.81 to $1.73. and has now fallen 4 days in a row. During the day the stock fluctuated 9.14% from a day low at $1.70 to a day high of $1.85.

Can you buy bngo on Robinhood?

About BNGO. Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for ...

Is BNGO stock a good buy right now?

Based on his analysis, DeGeeter rates BNGO stock as “outperform” with a $14 value. Other analysts are also bullish on the company. Those tracked by the Wall Street Journal have BNGO rated as a consensus “buy” with an average $12 price target.Dec 14, 2021

Is BNGO buy or sell?

Bionano Genomics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Is BNGO a US stock?

BNGO:USNASDAQ CM. Bionano Genomics Inc.

How much will BNGO go up?

Stock Price Forecast The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +262.32% increase from the last price of 2.07.

Is BNGO a pump and dump?

BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.May 7, 2021

What type of stock is BNGO?

Common Stock (BNGO)

Who owns Bionano genomics?

The Vanguard Group, Inc.

What is the short interest in BNGO?

Bionano Genomics currently has a short interest ratio of 5.0.

Is BNGO in Russell?

(Nasdaq: BNGO) announced today that it was added as a member of the US small-cap Russell 2000® Index, effective after the US market opens on Monday, June 28, 2021, as part of the 2021 Russell indexes reconstitution.Jun 28, 2021

What is BNGO price target?

Stock Price TargetsHigh$14.00Median$7.50Low$6.00Average$8.75Current Price$1.9800

Will Zom stock go up?

There is potential for a short term uptick in the Zom stock price, especially as the active weekly candle is mildly bullish. The relative strength index is relatively oversold and has been for quite some time.Feb 4, 2022

How to buy shares in Bionano Genomics

Compare share trading platforms. Use our comparison table to help you find a platform that fits you.

Buy Bionano Genomics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Bionano Genomics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Bionano Genomics share dividends

We're not expecting Bionano Genomics to pay a dividend over the next 12 months.

Bionano Genomics share price volatility

Over the last 12 months, Bionano Genomics's shares have ranged in value from as little as $1.81 up to $11.53. A popular way to gauge a stock's volatility is its "beta".

Bionano Genomics overview

Bionano Genomics, Inc. , a genome analysis company, provides tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing.

Frequently asked questions

What percentage of Bionano Genomics is owned by insiders or institutions?

Signals & Forecast

There are mixed signals in the stock today. The BioNano Genomics Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.

Support, Risk & Stop-loss

BioNano Genomics Inc. finds support from accumulated volume at $1.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

Is BioNano Genomics Inc. stock A Buy?

BioNano Genomics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Insiders are very positive buying more shares than they are selling in BioNano Genomics Inc

In the last 100 trades there were 23.1 million shares bought and 8.97 million shares sold. The last trade was done 6 days ago by Holmlin R. Erik who bough 1.4 million shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Bionano Genomics

Some stock charts might currently not be supported. To try again, please refresh this page.

About BNGO

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space.

Rating

What analysts recommend for this stock, on a scale from 1 (buy) to 5 (sell).

About Bionano Genomics

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space.

Bionano Genomics (NASDAQ:BNGO) Frequently Asked Questions

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bionano Genomics in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Bionano Genomics stock. View analyst ratings for Bionano Genomics or view top-rated stocks.

What is an X industry?

The X Industry (aka Expanded Industry) is a subset of the M (Medium Sized) Industry, which is a subset of the larger Sector category, which is used to classify all of the stocks in the Zacks Universe. The Zacks database contains over 10,000 stocks.

What is value scorecard?

The Value Scorecard identifies the stocks most likely to outperform based on its valuation metrics. This list of both classic and unconventional valuation items helps separate which stocks are overvalued, rightly lowly valued, and temporarily undervalued which are poised to move higher.

What is a strong weekly advance?

A strong weekly advance (especially when accompanied by increased volume) is a sought after metric for putting potential momentum stocks onto one's radar. Others will look for a pullback on the week as a good entry point, assuming the longer-term price changes (4 week, 12 weeks, etc.) are strong.

Is a B better than a C?

An A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. Value Score A. As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B.

Does Zackstrade endorse or recommend investment strategies?

The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.

What is the good news about Bionano?

The good news for Bionano is that its technology sets it apart from others. The company focuses on cytogenomics -- the detection of genetic disorders by analyzing the differences in chromosomes. In particular, Bionano's technology looks for large structural variations that can cause diseases.

What is the 800 pound gorilla?

Illumina, for example, is the 800-pound gorilla in what's called short-read sequencing, a cost-effective approach that can be performed at very high throughputs. Oxford Nanopore and Pacific Biosciences of California are leaders in long-read sequencing, which can sequence parts of the genome that short reads can't.

Is Bionano a competitive advantage?

How Bionano is doing so far. A competitive advantage isn't enough by itself to make a company successful. After all, the metaphorical junkyard is filled with technologies that were once widely viewed as better than alternatives. A company has to execute very well to capitalize on its competitive edge.

Is Bionano stock going up in 2021?

Bionano stock has more than quadrupled so far in 2021. The company's market cap has skyrocketed more than 600%, generating stronger growth than its share price because of two diluting stock offerings.

Can Bionano detect structural variations?

Their sequencing systems can't reliably detect the large structural variations that Bionano's Sapphire system can. It's not surprising, therefore, that medical research institutions like Duke University, the Mayo Clinic, and Penn State College of Medicine have turned to Sapphire to research multiple diseases.

Is Bionano losing money?

The company continues to lose a lot of money -- nearly $10.8 million in its last reported quarter. Bionano's bottom line is getting worse rather than better as its spending increases significantly. However, that's not all that unusual for companies in their early stages of growth.